Published: 11-09-2014 16:12 | Updated: 11-09-2014 16:50
Publication in Science: Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Zongli Zheng, postdoctoral fellow at the Department of Medical Epidemiology and Biostatistics and Harvard Medical School has published an article in Science on how optimization of circulating tumor culture conditions may help identify the best therapies for individual cancer patients over the course of their disease.
Cancer therapy. Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility.
Science 2014 Jul;345(6193):216-20